ReviewFrontiers in oncology2024

Progress and prospects of biomarker-based targeted therapy and immune checkpoint inhibitors in advanced gastric cancer.

Zhu Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.